Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

Crossing your legs is one of those every day moves that could be inadvertantly contributing to your back pain or high blood ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr.

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from ...

It’s one of the tenets of physical fitness, so why is flexibility overlooked by researchers and the average person putting on ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...

Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...